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The purpose of this study is to characterize the delivery dynamics of single-molecule 
fluorescent probes, MTRIPS (multiply labeled tetravalent RNA imaging probes), with 
Streptolyosin-O (SLO) reversible membrane permeabilization.   The delivery or MTRIPs 
was quantified in A549 human adenocarcinoma lung cells.  Increase in MTRIP delivery 
concentrations positively correlated to high MTRIP concentrations in the cytoplasm of 
the cells.  Conversely, the use of varying SLO concentrations with a fixed MTRIP 
concentration exhibited no distinct change in intracellular MTRIP concentrations, except 
for high SLO concentrations specifically at 50U mL
-1
.   Additionally, the effects of 
MTRIP delivery with SLO were observed in MDCK, Vero, U2OS, and HEp2 cells.   
Observable differences in intracellular MTRIP concentrations were observed in MDCK, 
U2OS, and HEp2 cells.  However, even at high SLO concentrations, the intracellular 
MTRIP concentration was not significant in Vero cells.  This understanding of the 
dynamics of SLO delivery for fluorescent probes is crucial to targeting endogenous RNA 








Almost all cellular function is regulated by complex interactions of 
macromolecules, such as proteins, lipids, DNA, and RNA.  These molecular interactions 
are the basis of reproduction, metabolism, maintenance, growth, and, essentially, life.  
Disruption in any of these molecular interactions could lead to the onset or progression of 
disease.  Therefore, identification of these specific interactions and their components is 
vital to understanding the fundamental mechanisms of cellular processes in order to deter 
the proliferation of disease and find a method for treatment. 
Fluorescence microscopy is a vital tool for studying these molecular interactions 
within cells.  It has been useful for studying cells in vivo, within a living organism, and in 
vitro, within a controlled environment.   Most fluorescence microscopy studies involve 
dual-color images of specific molecules that demonstrate colocalization, or the degree of 
which two signals overlap when collected in separate detection channels for specific 
molecules [1].  The high degree of colocalization of certain molecules indicates close 
proximity and the likelihood of nonrandom interactions [1].  Colocalization allows for the 
visualization of these events but requires single-molecule sensitivity in order to track the 
progression of specific, individual molecules. 
 To track low abundance molecules, such as RNA or proteins, single molecule-
sensitive fluorescent probes are used and delivered into cells.  Single molecule-sensitive 
fluorescent probes have been used to detect conformational changes, protein expression, 
localization, trafficking and diffusion in vitro [2].  However, to track individual 
molecules within a cell, the single molecule-sensitive probes must be introduced into the 
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intracellular environment.  In order to introduce these single molecule-sensitive probes 
into the cell, the plasma membrane must be bypassed.  The plasma membrane forms a 
selectively permeable barrier that separates the cell from the exterior environment and 
regulates small molecule transport in and out of the cell [3].  To facilitate the 
visualization of RNA or proteins within the cell, exogenous fluorescent probes that bind 
to specific molecules within the cell are delivered across the plasma membrane.  To avoid 
degradation problems related to the endocytic pathway, where exogenous molecules are 
brought into the cell by vesicles, non-endocytic methods have been developed.  
Microinjection, electroporation, cell-penetrating peptides, and reversible membrane 
permeabilization are known methods for delivering probes into the cell by bypassing the 
plasma membrane barrier. With the exception of cell membrane permeabilization, these 
methods are technically demanding and restricted to small cell numbers  [4]. 
 Microinjection and electroporation are two well-established methods commonly 
used to introduce fluorescent probes into the cell. The microinjection procedure requires 
direct visualization of the cell and the use of a fine-tipped glass microcapillary to inject 
[5].  However, it is invasive, may interfere with metabolic processes and mRNA 
expression, and only allows for delivery of very small sample volumes into the cell [6].  
The increase in intracellular volume may even cause mechanical damage to the cell.  
Additionally, this procedure is technically demanding, time consuming, cost ineffective, 
and can only be performed in a small number of cells [6].   Electroporation is a technique 
that utilizes an electric pulse to bypass the plasma membrane for fluorescent probes to 
enter.  This technique has been found to be less efficient in exogenous probe delivery and 
has a lower rate of cell viability than other methods [5, 7]. 
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Although microinjection and electroporation are practiced methods for probe 
delivery, each method has limitations that affect the efficiency of delivery.  In a study 
performed by Delehanty et al., microinjection and electroporation are used to deliver 
quantum dots, or luminescent semiconductor nanocrystals, to an intracellular 
environment.  Both methods bypass the endocytic pathway and deliver materials without 
the need for endosomal escape.  However, quantum dot delivery varies between the two 
methods.  Electroporation was found to be better technique for delivering large quantities 
of quantum dots (~10
6
).  Although electroporation is successful in delivering larger 
quantities, it was noted that there is usually a high cellular mortality rate due to the 
subjugation of membrane permeabilization and a delivery of a strong electrical pulse.  
Additionally, there were problems with intracellular aggregation of the electroporated 
particles.  In comparison, microinjection induced a lower rate of cell death; however, 
only a small number of cells were successfully injected.  This is due to individual cell 
selection, the need for a well-trained operator, and physical constraints such as cell 
morphology, membrane thickness, and cell height.  Microinjection is also costly, with 
devices ranging from $30-$40,000, relative to electroporation devices which are less than 
$5,000 [5]. 
 An alternative method of delivery is with the use of cell-penetrating peptides to 
deliver fluorescent probes by translocating them through the plasma membrane.  This 
process involves binding the molecule of interest to a cell-penetrating peptide in order for 
it to translocate into the cell.  This technique has been proven to be useful for the delivery 
of fluorescent probes; however, cell-penetrating peptides have shown to be cargo-specific 
in their mechanisms of action and to have toxic effects on the cell at high concentrations.  
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Furthermore, since the mechanism for this process is not well understood, this method of 
delivery could potentially have additional unknown side effects [8]. 
Although cell-penetrating peptide delivery may be a valuable, alternative way to 
deliver probes, there have been multiple limitations observed with this delivery method.   
In a study performed by Zorko et al., cell-penetrating peptides were determined to be 
useful for drug delivery of small molecules, proteins, and supramolecular particles.  In 
this study, the internalization of cell-penetrating peptides and their cargo were monitored, 
and it was determined that the internalization of cell-penetrating peptides occurred at a 
fast rate (< 1 hour of incubation).  Small cargoes were determined to have no effect on 
the rate of internalization, while larger hydrophilic cargos (proteins) were internalized 
more slowly.  Additionally, more than 50% of the maximal internalization of cell-
penetrating peptides was achieved.  Even though the results were promising for drug 
delivery, this relatively new process is still not well understood.  The mechanism of 
internalization has not yet been resolved; however, it was shown that some cell-
penetrating peptides rely on the cellular membrane composition or may be linked to 
endocytic pathways, which requires additional mechanisms for endosomal escape.  Cell-
penetrating peptides have also shown some levels of toxicity on membranes of cells and 
organelles, which result in specific interactions of cell-penetrating peptides with wall 
components.  Some specific cell-penetrating peptides have even been observed to inhibit 
GTPase activity within the cell.  The stability of cell-penetrating peptides has also been 
problematic.  High extracellular stability could aid in efficient cargo delivery; however, 
high intracellular stability could result in the accumulation of cell-penetrating peptides 
that could engender side effects [8]. 
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In contrast to these three costly, technically demanding, and ambiguous methods, 
Steptolysin-O (SLO) reversible membrane permeabilization is a simple, effective 
technique for probe delivery that maintains cell viability, does not utilize endosomes, and 
prevents degradation of probes [7].  Streptolysin-O is a toxin produced by most strains of 
beta- hemolytic group A Streptococci and is used to perform reversible membrane 
permeabilization, a process in which SLO proteins bind to surface cholesterol on cell 
membranes and form functional pores [9] that can reach up to 35 nanometers in diameter 
[4].  The formation of these pores can be reversed in the presence of high magnesium and 
calcium environments, allowing for reversible membrane permeabilization.  The use of 
SLO enhances the intracellular uptake of large molecules within cells [7] and is useful in 
the delivery of nanoparticles into living cells, including exogenous fluorescent probes 
[10].   
The efficacy of fluorescent molecule SLO delivery was shown to achieve higher 
intracellular concentrations [6] without significantly effecting cellular functions[4].  In a 
study performed by Spiller et al, the delivery of oligonucleotides utilizing electroporation 
and SLO reversible membrane permeabilization were compared.  It was shown that most 
cells permeabilized with SLO contained higher concentrations of oligonucleotides than 
electroporated cells.  Additionally, cells treated with a supraoptimal dose of SLO, 
designed to have equivalent levels of toxicity to electroporation (12-14% cell death), had 
a rate of less than 5% cell death.[7]  Furthermore in a corresponding study performed by 
Walev et al, the effect of SLO permeabilization on cellular functions was proven to be 
minimal.  SLO permeabilized cells were shown to remain viable for days, to retain 
endocytic functions, and to proliferate normally.  Initially, cells treated with SLO 
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exhibited 80% ATP depletion but were able to gradually recuperate 50-90% of their 
original ATP levels after four hours.  It was also shown that cells treated with SLO 
showed no changes in glycoslyation patterns,  which indicates that cellular components 
were not lost to the extracellular environment.[4]   
The use of SLO reversible membrane permeabilization appears to be the optimal 
technique to deliver exogenous probes into a cell due to the lack of endosomal uptake, the 
high levels of cell viability, and the enhanced intracellular uptake of exogenous 
molecules.  Although the molecular mechanisms for SLO are well known, the dynamics 
of SLO delivery for fluorescent molecules are not yet well characterized.  It is not well 
understood how the concentration of fluorescent probe delivered to the cells or the 
concentration of SLO used affects the intracellular concentrations of probe taken up by 
the cell.  Expanding current research with SLO may lead to advances in molecular 
fluorescent-imaging techniques by optimizing intracellular concentrations of fluorescent 
molecules within cells.  This in turn can lead to a better imaging or tracking of single 
endogenous RNA or protein molecules. 
The dynamics of SLO delivery were observed by delivering fluorescent probes 
into the cytoplasm of A549 lung carcinoma cells.  It was hypothesized that the 
intracellular concentration of fluorescent probes can be controlled by manipulating the 
concentrations of probe delivered or by controlling the amount SLO used during the 
delivery.  In addition, the effects of fluorescent probe delivery using SLO varying were 
observed with varying cell types.   
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MATERIALS AND METHODS 
MTRIPS (multiply labeled tetravalent RNA imaging probes) were delivered into A549 
lung carcinoma cells using Streptolyosin-O (SLO).  Images were captured using 
fluorescence microscopy and data was analyzed using Volocity software.   
MTRIPs.  MTRIPs were created by binding 2’ O-methyl RNA-DNA chimera nucleic 
acid ligands with 5’ biotin and multiple dT-C6-NH2 modifications, manufactured by 
Biosearch Technologies Inc.  Streptavidin purchased from Pierce were used for the core 
of the MTRIPs.  Probes were assembled by resuspending the purified RNA-DNA ligands 
with bound fluorphores in phosphate-buffered saline (PBS; pH 7.4) and mixed at a 10:1 
molar ratio with steptavidin for 1 hour at room temperature (18-22°C) as seen in Figure 1.  
Free ligands were removed with a 30 kDa Nanosep spin column and stored at 1µM final 
concentration in PBS at 4°C.  
 
Figure 1. RNA-DNA chimera nucleic acid 
ligands were bound to Cy3B fluorophores.  
Streptavadin was used as the core and bound to 
the ligands with fluorophores, and excess 





Santangelo et Al. 2009 
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Cells.  A549 lung carcinoma cells (American Type Culture Collection CCL-185) were 
grown in DMEM (Sigman Aldrich) with 10% fetal bovine serum (FBS; Hyclone) with 
100 U
-1
 of penicillin and 100 mg ml 
-1
 of streptomycin.  Identical cell culture procedures 
were used for the (MDCK) Madin-Darby Canine Kidney epithelial cells, (Vero C1008) 
African green monkey kidney epithelia cells, (U2OS) human osteosarcoma cells, and 
(HEp2) human epidermoid cancer cells.  
Probe Delivery.  MTRIPs were delivered into A549 cells with streptolysin O (Sigma S-
5265) as seen in Figure 2.  SLO at 2U mL
-1
 was combined with TCEP bond breaker and 
incubated at 37°C for an hour.  After incubation, SLO was diluted 1:10 with Optimem.  
Then, optimem diluted MTRIPs were added to the SLO delivery solution.  Cells used for 
delivery were grown in complete medium and were initially washed with PBS.  They 
were then incubated with SLO and probe for ten minutes at 37°C.  The mixture of SLO 
and probes was removed and replaced with fresh, complete growth medium for fifteen 
minutes at 37°C.  
 
Figure 2. MTRIPs were delivered into cells 
using SLO delivery solution.  Pores formed 
were then recovered in a calcium and 
magnesium rich environment using complete 





Santangelo et Al. 2009 
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Staining.  A549 cells were fixed in 4% paraformaldehyde solution for ten minutes at 
room temperature.  They were then washed three times with PBS and permeabilized with 
0.2% Triton-X 100 for five minutes at room temperature.  After permeabilization, the 
cells were washed in PBS, blocked for thirty minutes in 5% BSA (ultrapure).  After they 
were washed in PBS, the cells were stained with Phalloidin 488 for thirty minutes at 37°C 
and washed three times with PBS.  Nuclei were stained with DAPI for five minutes at 
room temperature and then mounted with Prolong antifade reagent on glass slides.   
Fluoresence imaging.  Immobilized Cy3B probes on the glass surface were imaged with 
a Zeiss Axiovert 200M microscope with an X63, NA=1.4 Plan-Apochromat objective 
using chroma 49004 ET-Cy3 and 49006 ET-Cy5 filter sets with 500-ms exposures.  An 
EXFO excite 120 light source with a ND (neutral density) = 0.4% (40% transmission) 
was used for fluorescence excitation and a Hamamatsu ORCA-ER Ag camera for taking 
digital images.  All images were collected with Volocity software.   Seven to ten cell 
images were taken for each case using a Cy3B channel for probe, a FITC channel for 
actin filaments and cell structure, and a DAPI channel for the nucleus.   
Data Analysis.  MTRIPs were quantified using Volocity tracking software.   Images were 
deconvolved, and probes were identified by florescent intensity and size.  The quantity of 
probes present inside the cells were counted and analyzed.  Probes were counted in 
deconvolved images using SD intensity.  They were then clipped to the region of interest 
(ROI).  Touching objects were separated if the object was greater than 0.05µm
3
, and 







In order to determine the rate of MTRIPs present in the cytoplasm of cells, 
respiratory syncytial virus (RSV) targeted MTRIPs were delivered to noninfected human 
adenocarcinoma A549 cells.  The non-specific binding of RSV MTRIPs allowed for 
probes to freely move through pores created by SLO and into the cytoplasm.  MTRIP 
concentrations were then visualized using fluorescence microscopy and were counted 
using Volocity’s tracking software.  The quantity of probes present in the cell was 
collected from seven to ten cells for each case.   
Initially, probe delivery was observed in the no SLO and SLO delivery cases in 
Figure 3.  Probe was delivered at a 1nM concentration in Optimem control and 2U mL
-1
 
of SLO.  In the no SLO case, fewer MTRIPs were observed than in the SLO condition.  
Some MTRIPs were observed due to residual probe adhereing to the surface of cells; 
however, no probe appeared to be present inside the cytoplasm of cells.  Although 
residual binding of probse to the surface of cells is present, the quantity of probes present 





















Figure 3.  1nM of RSV Cy3B MTRIPs were delivered in Optimem for the control case, and 1nM of RSV 
MTRIP in 2U mL
-1
 of SLO diluted 1:10 with Optimem in A549 cells.  Cells were cultured in DMEM media 
with 10% FBS and with 100 U
-1
 of penicillin and 100 mg ml 
-1
 of streptomycin.  Cells were washed with Ca 
and Mg free PBS before MTRIP delivery with SLO.  MTRIPs in Optimem and SLO were delivered to the 
cells and incubated for ten minutes at 37°C.   Following the delivery, cells were recovered in complete 
DMEM media for fifteen minutes at 37°C, fixed in 4% paraformaldehyde for ten minutes at room 
temperature, and stained.  Images were captured and probes were quantified with Volocity software.  Green 
represents the cell structure; blue represents the nuclei (DAPI); and red represents the MTRIPs (Cy3):  lower 
case images indicate the same cell but only with the DAPI and Cy3 channels A) Single cell with a no SLO 
MTRIP delivery  B) Single cell with 2U mL
-1
 SLO MTRIP delivery  C) Comparison of average MTRIPs in 
the cell for the no slo and slo delivery cases 
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The dependence of MTRIP delivery based on on probe concentration was initially 
tested as seen in Figure 4.  Varying concentrations of MTRIP at 5nM, 10nM, and 30nM 
were delivered with SLO at 2U mL
-1
.  These results indicated a linear trend in which 
higher MTRIP delivery concentrations result in higher delivered concentrations into the 
cytoplasm.  A large increase of MTRIPs inside the cell was observed from 5nM to 10nm 
and from 10nM to 30nM.  This result indicated that the more available probe delivered 




















Figure 4.  5nM, 10nM, and 30nM of RSV Cy3B MTRIPs were delivered in 2U mL
-1
 of SLO diluted 1:10 with 
Optimem in A549 cells.  Cells were cultured in DMEM media with 10% FBS and with 100 U
-1
 of penicillin and 
100 mg ml 
-1
 of streptomycin.  Cells were washed with Ca and Mg free PBS before MTRIP delivery with SLO.   
5nM, 10nM, and 30nM of RSV Cy3B MTRIPs were delivered in 2U mL
-1
 of SLO diluted 1:10 with Optimem.   
MTRIPs in SLO were delivered to the cells and incubated for ten minutes at 37°C.   After the delivery, cells were 
recovered in complete DMEM media for fifteen minutes at 37°C, fixed in 4% paraformaldehyde for ten minutes 
at room temperature, and stained.  Images were captured and probes were quantified with Volocity software. 
Green represents the cell structure; blue represents the nuclei (DAPI); and red represents the MTRIPs (Cy3):  
lower case images indicate the same cell but only with the DAPI and Cy3 channels A) Single cell with 2U mL
-1 
SLO MTRIP delivery with MTRIPs concentrated at 5nM  B) Single cell with 2U mL
-1 
SLO MTRIP delivery 
with MTRIPs concentrated at 10nM  C) Single cell with 2U mL
-1 
SLO MTRIP delivery with MTRIPs 
concentrated at 3nM  D) Comparison of average MTRIPs in the cell for MTRIPs concentrated at 5nM, 10nM, 
and 30nM 
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The dependence of MTRIP delivery based on varying SLO concentrations were 
visualized in Figure 5.  1nM of RSV MTRIPs were delivered with varying concentrations 








, and 50U mL
-1
.  It was observed that 
minimal amounts of probe were delivered to the cells at the 0.2U mL
-1
 SLO case.  For 




 SLO cases, similar quantities of probe were observed in 
cells.  However, for the 2U mL
-1
 SLO case, a higher quantity of probe was visualized 
inside the cells.  No notable differences in MTRIP concentration inside the cell were 




, and 10U mL
-1
 SLO cases.  However, for 
MTRIPs delivered at 50U mL
-1
 of SLO, an increase in intracellular MTRIP concentration 
was observed.  From this data, it appears that the optimal MTRIP delivery concentration 
using minimal amounts of MTRIP and SLO can be reached using 2U mL
-1
 of SLO.  
However, to effectively deliver more MTRIPs, 50U mL
-1
 of SLO can be used on A549s 




























Figure 5.  1nM  RSV Cy3B MTRIPs were delivered in 0.2U mL
-1
,  2U mL
-1
, 5 U mL
-1
 ,10 U mL
-1
, and 50 
U mL
-1 
of SLO diluted 1:10 with Optimem in A549 cells.  These cells were cultured in DMEM media with 
10% FBS and with 100 U
-1
 of penicillin and 100 mg ml 
-1
 of streptomycin.  Cells were washed with Ca and 
Mg free PBS before MTRIP delivery with SLO. MTRIPs in SLO were delivered to the cells and incubated 
for ten minutes at 37°C.   Cells were then recovered in complete DMEM media for fifteen minutes at 37°C, 
fixed in 4% paraformaldehyde for ten minutes at room temperature, and stained.  Images were captured and 
probes were quantified with Volocity software.  Green represents the cell structure; blue represents the 
nuclei (DAPI); and red represents the MTRIPs (Cy3):  lower case images indicate the same cell but only 
with the DAPI and Cy3 channels A) Single cell with 0.2U mL
-1 
SLO MTRIP delivery  B) Single cell with 
2U mL
-1 
SLO MTRIP delivery  C) Single cell with 5U mL
-1 
SLO MTRIP delivery  D) Single cell with 10U 
mL
-1 
SLO MTRIP delivery  E) Single cell with 30U mL
-1 
SLO MTRIP delivery  F) Comparison of average 
MTRIPs delivered at varying SLO concentrations 
 
 The effect of MTRIP delivery using SLO was also observed in varying cell types.  
MTRIP delivery was performed in four different cell lines: Madin-Darby Canine Kidney 
(MDCK) epithelial cells, African green monkey kidney (Vero) epithelial cells, human 
osteosarcoma cells (U2OS), and human epidermoid cancer cells (HEp2).  Initially, 
MTRIP delivery was performed using 2U mL
-1 
of SLO.  However, no observable 
differences of delivery with no SLO and SLO were present.  In order to examine 
significant changes in delivery, 100U mL
-1
 of SLO were used to deliver 1nM of RSV 
MTRIPs as seen in Figure 5.  A considerable difference was observed for the MDCK cell 
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line where a threefold increase was observed with SLO delivery than in the no SLO case.  
It was observed in the no SLO case of MDCKs that residual MTRIPs had a tendency to 
adhere to the cell surface.  For Vero cells, no noticeable difference in MTRIPs was 
observed in the no SLO and SLO cases.  Both cases displayed a similar number of 
MTRIPs present or adhered to the surface.  Fewer MTRIPs were also observed to adhere 
less to the MDCK cells than the MDCK or U2OS cells.  The insignificant difference 
between the no SLO and SLO delivery cases in the Veros may be dependent upon cell 
morphology.  If these cells are flatter, MTRIPs may be less likely to move down the 
concentration gradient and passively diffuse through the created pores into the cytosolic 
space.  In U2OS cells, a twofold increase in MTRIP concentration was observed with 
SLO delivery.  Similar numbers of MTRIPs appeared to adhere to the surface of U2OS 
cells as those that adhered to the MDCK cells.  In HEp2 cells, a threefold increase was 
observed with SLO delivery.  However, the quantity of MTRIPs inside the cell was 
significantly less than those present in the other cell types.  This characteristic may also 
relate to the specific cell morphology.  Additionally, very few MTRIPs appeared to 
adhere to the cell surface.  Higher concentrations of SLO seemed to work more 
effectively on several cell types.  No significant differences in MTRIP concentrations 
were observed when no SLO and 2U mL
-1
 of SLO were used.  However, significant 
differences in MTRIP concentration were observed in MDCK, U2OS, and HEp2 cells 
using 100U mL
-1
 of SLO. 
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no SLO           100U mL
-1
 SLO           no SLO      100U mL
-1




Figure 6.  1nM RSV Cy3B MTRIPs were delivered in 100U mL
-1
of SLO diluted 1:10 with Optimem in 
MDCK, Vero C1008, U2OS, and HEp2 cells.  These cells were cultured in DMEM media with 10% FBS and 
with 100 U
-1
 of penicillin and 100 mg ml 
-1
 of streptomycin.  Cells were washed with Ca and Mg free PBS 
before MTRIP delivery with SLO.  MTRIPs in SLO were delivered to the cells and incubated for ten minutes 
at 37°C.   Cells were then recovered in complete DMEM media for fifteen minutes at 37°C, fixed in 4% 
paraformaldehyde for ten minutes at room temperature, and stained.  Images were captured and probes were 
quantified with Volocity software.  Green represents the cell structure; blue represents the nuclei (DAPI); and 
red represents the MTRIPs (Cy3):  lower case images indicate the same cell but only with the DAPI and Cy3 
channels  A) Single MDCK cell with no SLO MTRIP delivery  B) Single MDCK cell with 100U mL
-1 
SLO 
MTRIP delivery  C) Single Vero cell with no SLO MTRIP delivery  D) Single Vero cell with 100U mL
-1 
SLO MTRIP delivery  E) Single U2OS cell with no SLO MTRIP delivery  F)Single U2OS cell with 100U 
mL
-1 
SLO MTRIP delivery G)Single HEp2 cell with no SLO MTRIP delivery H)Single HEp2 with 100U 
mL
-1 






 Differences in MTRIP delivery were observed in A549 cells by manipulating the 
MTRIP delivery concentration and partially adjusting the SLO delivery solution.  More 
MTRIPs were observed in the cytoplasm of cells when higher concentrations of MTRIPs 
were available, as in the 30nM delivery case in Figure 4C.  Additionally, the abundance 
of MTRIPs in the SLO delivery environment positively correlated to the quantity of 
MTRIPs observed in the cytoplasm.  Altering the concentration of MTRIPs in the SLO 
delivery solution was effective in increasing the cytosolic concentration of MTRIPs in 
cells; however, adjusting SLO concentrations did not dramatically increase the cytosolic 
content of MTRIPs in cells.  No distinguishable differences in MTRIP concentration 
were observed in the 2, 5, and 10U mL
-1
 SLO concentrations.  There was no positive 
correlation between increased SLO concentration and cytosolic MTRIP concentrations.  
Of the lower SLO concentrations, 2U mL
-1
 of SLO had more effective delivery than that 
of the 0.2,5, and 10U mL
-1
 of SLO cases.  The 50U mL
-1
 SLO delivery case did display a 
significant increase in intracellular MTRIP concentration.  This may indicate that only 
much higher concentrations of SLO are effective in binding to pores and creating the 
maximum amount passages for MTRIPs to travel through.   
 Additionally, varying cell types responded differently to the effects of SLO 
delivery.  MDCK, Vero, U2OS, and HEp2 cells presented no significant changes with 
untargeted MTRIPs delivered at 2U mL
-1
 of SLO.  In order to effectively determine 
changes in MTRIP concentration, 100U mL
-1
 of SLO was used and resulted in different 
results for each cell type.  MDCK, U2OS, and HEp2 cells were shown to have a twofold 
or threefold increase of MTRIPs in the cytoplasm.  Vero cells did not display any 
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significant difference in MTRIP delivery with no SLO and with SLO.  Adherence of 
MTRIPs to the cell membrane also varied with cell types.  More MTRIPs were observed 
on the surface of the MDCK and U2OS cells than on Vero or HEp2 cells.  It is currently 
not known why these fluorescent probes adhere to only specific cell surfaces, but it may 
occur due to varying quantities of different membrane proteins available on differing cell 
types.  Future studies to determine why cell type delivery differs could include 
quantifying the amount of available cholesterol for SLO to bind to in differing cell types 
or determining what membrane components affect the binding of MTRIPs to the cell 
surface for differing cell types.  More information on these factors could promote more 
efficient probe delivery in more cell types.  
Observations of SLO delivery dynamics with MTRIPs provides detailed 
information on how to effectively deliver fluorescent probes to an intracellular 
environment.  Optimizing the amount of probes that can be delivered is crucial to 
targeting all of the available endogenous RNA or proteins within the cell.  Efficiently 
targeting all the available mRNA or proteins will allow for a more accurate 
representation of molecular which in turn can lead to better, long-term imaging to 
visualize real-time molecular processes and can eventually alleviate the gap of 
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